A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis
Public ClinicalTrials.gov record NCT05152563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of Subcutaneous AK002 in Subjects With Moderate to Severe Eosinophilic Gastritis and/or Eosinophilic Duodenitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, tolerability, and pharmacodynamic effect of subcutaneous lirentelimab (AK002), given monthly for 6 doses, in subjects with moderate to severe Eosinophilic Gastritis and/or Eosinophilic Duodenitis who have an inadequate response with, lost response to, or were intolerant to standard therapies.
Study identification
- NCT ID
- NCT05152563
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2021 (Estimated)
- Primary completion
- Jan 20, 2022 (Actual)
- Completion
- Jan 20, 2022 (Actual)
- Last update posted
- Mar 3, 2023
2021 – 2022
United States locations
- U.S. sites
- 76
- U.S. states
- 31
- U.S. cities
- 73
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Allakos Investigational Site | Birmingham | Alabama | 35205 | — |
| Allakos Investigational Site | Gilbert | Arizona | 85234 | — |
| Allakos Investigational Site | Phoenix | Arizona | 85021 | — |
| Allakos Investigational Site | Scottsdale | Arizona | 85250 | — |
| Allakos Investigational Site | Chula Vista | California | 91910 | — |
| Allakos Investigational Site | Long Beach | California | 90808 | — |
| Allakos Investigational Site | Ventura | California | 93003 | — |
| Allakos Investigational Site | Walnut Creek | California | 94598 | — |
| Allakos Investigational Site | Bristol | Connecticut | 06010 | — |
| Allakos Investigational Site | Brandon | Florida | 33511 | — |
| Allakos Investigational Site | Edgewater | Florida | 32132 | — |
| Allakos Investigational Site | Jacksonville | Florida | 32256 | — |
| Allakos Investigational Site | Kissimmee | Florida | 34741 | — |
| Allakos Investigational Site | Miami | Florida | 33125 | — |
| Allakos Investigational Site | New Port Richey | Florida | 34653 | — |
| Allakos Investigational Site | Ponte Vedra | Florida | 32081 | — |
| Allakos Investigational Site | Sunrise | Florida | 33351 | — |
| Allakos Investigational Site | Tampa | Florida | 33603 | — |
| Allakos Investigational Site | Tampa | Florida | 33612 | — |
| Allakos Investigational Site | Atlanta | Georgia | 30342 | — |
| Allakos Investigational Site | Sandy Springs | Georgia | 30328 | — |
| Allakos Investigational Site | Chicago | Illinois | 60611 | — |
| Allakos Investigational Site | Iowa City | Iowa | 52242 | — |
| Allakos Investigational Site | Kansas City | Kansas | 66160 | — |
| Allakos Investigational Site | Crowley | Louisiana | 70526 | — |
| Allakos Investigational Site | Shreveport | Louisiana | 71105 | — |
| Allakos Investigational Site | Glen Burnie | Maryland | 21061 | — |
| Allakos Investigational Site | Boston | Massachusetts | 02111 | — |
| Allakos Investigational Site | Boston | Massachusetts | 02215 | — |
| Allakos Investigational Site | Ann Arbor | Michigan | 48104 | — |
| Allakos Investigational Site | Wyoming | Michigan | 49519 | — |
| Allakos Investigational Site | Rochester | Minnesota | 55905 | — |
| Allakos Investigational Site | Bay Saint Louis | Mississippi | 63106 | — |
| Allakos Investigational Site | Flowood | Mississippi | 39232 | — |
| Allakos Investigational Site | Kansas City | Missouri | 64108 | — |
| Allakos Investigational Site | Kalispell | Montana | 59901 | — |
| Allakos Investigational Site | Reno | Nevada | 89511 | — |
| Allakos Investigational Site | Lebanon | New Hampshire | 03756 | — |
| Allakos Investigational Site | Florham Park | New Jersey | 07932 | — |
| Allakos Investigational Site | Freehold | New Jersey | 07728 | — |
| Allakos Investigational Site | Great Neck | New York | 11023 | — |
| Allakos Investigational Site | New York | New York | 10029 | — |
| Allakos Investigational Site | Chapel Hill | North Carolina | 27599 | — |
| Allakos Investigational Site | Charlotte | North Carolina | 28204 | — |
| Allakos Investigational Site | Concord | North Carolina | 28027 | — |
| Allakos Investigational Site | Durham | North Carolina | 27710 | — |
| Allakos Investigational Site | Raleigh | North Carolina | 27607 | — |
| Allakos Investigational Site | Winston-Salem | North Carolina | 27157 | — |
| Allakos Investigational Site | Cincinnati | Ohio | 45229 | — |
| Allakos Investigational Site | Columbus | Ohio | 43210 | — |
| Allakos Investigational Site | Dayton | Ohio | 45415 | — |
| Allakos Investigational Site | Mentor | Ohio | 44060 | — |
| Allakos Investigational Site | Springboro | Ohio | 45066 | — |
| Allakos Investigational Site | Westlake | Ohio | 44145 | — |
| Allakos Investigational Site | Oklahoma City | Oklahoma | 73102 | — |
| Allakos Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Allakos Investigational Site | Greenwood | South Carolina | 29646 | — |
| Allakos Investigational Site | Chattanooga | Tennessee | 37421 | — |
| Allakos Investigational Site | Germantown | Tennessee | 38138 | — |
| Allakos Investigational Site | Hixson | Tennessee | 37343 | — |
| Allakos Investigational Site | Nashville | Tennessee | 37212 | — |
| Allakos Investigational Site | Austin | Texas | 78757 | — |
| Allakos Investigational Site | El Paso | Texas | 79905 | — |
| Allakos Investigational Site | Fort Worth | Texas | 76104 | — |
| Allakos Investigational Site | Lubbock | Texas | 79410 | — |
| Allakos Investigational Site | San Antonio | Texas | 78229 | — |
| Allakos Investigational Site | Southlake | Texas | 76092 | — |
| Allakos Investigational Site | Webster | Texas | 77598 | — |
| Allakos Investigational Site | Wichita Falls | Texas | 76301 | — |
| Allakos Investigational Site | Ogden | Utah | 84405 | — |
| Allakos Investigational Site | Riverton | Utah | 84065 | — |
| Allakos Investigational Site | Salt Lake City | Utah | 84112 | — |
| Allakos Investigational Site | Sandy City | Utah | 84092 | — |
| Allakos Investigational Site | Fairfax | Virginia | 22031 | — |
| Allakos Investigational Site | Seattle | Washington | 98115 | — |
| Allakos Investigational Site | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05152563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05152563 live on ClinicalTrials.gov.